capitolbuilding
Issue Background

Federal Legislation

Infection Prevention Funding in FY 2018

An omnibus bill to fund the government through September 30 was passed by Congress and signed by the President. The $1.3 trillion legislation was a compromise between Democrat and Republican priorities and provided stable funding for most APIC legislative priorities. However, when compared to FY 2017 levels, the omnibus bill did increase funding for several healthcare agencies.

Some highlights of the legislation are below:

  • Department of Health and Human Services received an increase of $10 billion;
  • National Institutes of Health was provided an additional $3 billion;
    • including an additional $40 million for research into a universal flu vaccine;
  • Centers for Disease Control and Prevention saw an increase of $840 million; and
  • Agency for Healthcare Research and Quality received an additional $10 million.

Below is a chart outlining how infection prevention programs fared this year when compared to the previous year. 

Federal Government Program

FY 2017

FY 2018

Emerging and Zoonotic Infectious Diseases Programs

 

 

Antibiotic Resistance Initiative

$163,000,000

$168,000,000

National Healthcare Safety Network

$21,000,000

$21,000,000

Advanced Molecular Detection

$30,000,000

$30,000,000

Prevention and Public Health Fund (PPHF)

 

 

Immunizations

$324,350,000

$324,350,000

Epidemiology and Lab Capacity program

$40,000,000

$40,000,000

Healthcare-Associated Infections

$12,000,000

$12,000,000

Agency for Healthcare Research and Quality (AHRQ)

 

 

Healthcare-Associated Infections Prevention

$36,000,000

$36,000,000

National Institutes of Health (NIH)

 

 

National Institute of Allergy and Infectious Diseases

$4,900,000,000

$5,260,210,000

 

2018 Testimony and Fact Sheets

  • On April 26, APIC and SHEA submitted joint testimony to the House Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies asking the subcommittee to support key infection prevention programs.  
  • On April 9, the CDC Coalition submitted a letter to the House and Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies requesting them to fund the CDC at $8.445 billion. 
  • On March 19, APIC joined a coalition letter being led by the American Thoracic Society requesting members of Congress increase funding for domestic and international tuberculosis programs. 
  • On March 12, APIC joined a coalition letter urging the Assistant Secretary for Preparedness and Response (R&D) support new antimicrobial research and development (R&D) incentives in the reauthorization of the Pandemic and All Hazards Preparedness Act (PAHPA).
  • On February 26, APIC joined a S-FAR coalition letter in supporting the Strategies to Address Antimicrobial Resistance (STAAR) Act which was introduced by Senator Sherrod Brown. 
  • On February 6, a coalition of more than 50 organizations signed a letter encouraging Members of Congress to include an amendment to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization legislation. The letter encourages legislators to incentivize companies to develop new antimicrobials.
  • APIC signed another coalition letter asking Members of Congress not to cut any more funding from the Prevention and Public Health Fund. 
  • On January 8, APIC joined the Friends of AHRQ on a coalition letter asking Members of Congress to support equal or higher funding for the Agency for Healthcare Research and Quality (AHRQ). 


2017 Testimony and Fact Sheets

Coalition Efforts

  • APIC signed onto a coalition letter urging the National Institute of Food and Agriculture to protect antibiotic research funding in FY 2018. 
  • The CDC Coalition signed a letter asking Congressional appropriators to provide the CDC with $7.8 billion in FY 2018. 
  • On October 23, APIC joined a coalition letter signed by 68 other organizations urging Congress to provide emergency supplemental funding to states impacted by hurricanes.  
  • The Friends of the National Quality Forum (NQF) wrote a letter to Chairman Kevin Brady urging him to continue the currently authorized $30 million in annual Medicare funding for the National Quality Forum. 
  • The U.S. Stakeholder Forum on Antimicrobial Resistance (S-FAR) sponsored a letter requesting Congress reject the President's FY 2018 budget and to create a bipartisan plan that provides the funding needed to address public health threats.  
  • More than 800 organizations, signed a letter asking the House and Senate Appropriations Committees to increase the FY 2018 302 (b) allocation for the Labor, HHS and Education subcommittees. 
  • The CDC Coalition signed a letter asking Congressional appropriators to provide the CDC with $7.8 billion in FY 2018. 
  • Coalition letter to the Acting Commissioner of the FDA asking the them to strenghten rules regarding labels on antibiotics for food animals. 
  • A coalition of over 2,000 organizations signed a letter requesting Members of Congress help protect non-defense discretionary spending in FY 2018. 
  • A wide-ranging coalition of health professionals, patient advocacy groups and veterinarians signed a letter urging President Trump not to include federal public health employees in his potential long-term hiring freeze Executive Order. 
  • The March of Dimes led a coalition effort requesting Senate Appropriators support funding levels necessary to properly combat Zika in FY2018. 
  • coalition letter sent to President Trump emphasized the importance and safety of vaccinations. 
  • APIC signed a coalition letter urging the Senate HELP and Finance Committees to use Representative Tom Price's confirmation hearings to ensure his support for immunization policy and infrastructure. 

Congressional Hearings related to infection prevention